Document is current

Any future updates will be listed below

Correction: Safety and efficacy of nab-paclitaxel combined with nedaplatin and bevacizumab in patients with platinum-resistant epithelial ovarian cancer: a retrospective cohort study

Crossref DOI link: https://doi.org/10.1007/s00432-026-06528-3

Published Online: 2026-06-16

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark